Showing results (81-90 of 139) with videos related to
Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2013
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspectiveTan To Cheung, Chi Lai Ho, Chung Mau Lo, et al.Cancer|February 26, 2024
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion studySarwan Bishnoi, Dusan Kotasek, Morteza Aghmesheh, et al.Journal of Hepatology|July 26, 2020
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaBruno Sangro, Ignacio Melero, Samir Wadhawan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre StudyJung Sun Kim, Jeffrey Wong, San-Chi Chen, et al.Journal of Hepatology|August 10, 2013
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinomaRichard S Finn, Ronnie T P Poon, Thomas Yau, et al.Hepatobiliary Surgery and Nutrition|October 27, 2023
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesionsTan-To Cheung, Yuk Tong Lee, Raymond Shing-Yan Tang, et al.Journal of Hepatology|June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysisThomas Yau, Chiun Hsu, Tae-You Kim, et al.Journal of Cachexia, Sarcopenia and Muscle|February 21, 2022
Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adultsEverson A Nunes, Lauren Colenso-Semple, Sean R McKellar, et al.The Oncologist|January 2, 2019
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular CarcinomaImane El Dika, Ho Yeong Lim, Wei Peng Yong, et al.Therapeutic Advances in Medical Oncology|October 7, 2021
ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240Arndt Vogel, Philippe Merle, Chris Verslype, et al.Pageof 14